Close

August 16, 2014

FDA reports positive trends in antimicrobial resistance

The U.S. Food and Drug Administration (FDA) yesterday released its National Antimicrobial Resistance Monitoring System (NARMS) 2011 Executive Report, showing mostly decreasing antimicrobial resistance trends. The annual NARMS Executive Report focuses on resistance to antibiotics that are considered important in human medicine as well as multidrug resistance (described as resistance to three or more classes of antibiotics), according to the FDA.  Under the NARMS program, samples are collected from human, food producing animals and retail meat sources, and tested for certain bacteria, specifically non-typhoidalSalmonellaCampylobacterE. coli and Enterococcus, to determine whether such bacteria are resistant to various antibiotics used in human and veterinary medicine. Read More

Leave a Reply